The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 28, 2016

Filed:

Jul. 01, 2015
Applicant:

Immunomedics, Inc., Morris Plains, NJ (US);

Inventors:

Serengulam V. Govindan, Summit, NJ (US);

Jonathan B. Gale, West Townsend, MA (US);

Nicholas J. Holman, Leominster, MA (US);

David M. Goldenberg, Mendham, NJ (US);

Assignee:

Immunomedics, Inc., Morris Plains, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/48 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61K 31/4745 (2006.01); A61K 48/00 (2006.01); A61K 31/337 (2006.01); A61K 31/4184 (2006.01); A61K 31/4375 (2006.01); A61K 31/454 (2006.01); A61K 31/513 (2006.01); A61K 31/675 (2006.01); A61K 31/7088 (2006.01); A61K 31/713 (2006.01); A61K 33/24 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); A61K 38/17 (2006.01); A61N 5/10 (2006.01);
U.S. Cl.
CPC ...
A61K 47/48569 (2013.01); A61K 31/337 (2013.01); A61K 31/4184 (2013.01); A61K 31/4375 (2013.01); A61K 31/454 (2013.01); A61K 31/4745 (2013.01); A61K 31/513 (2013.01); A61K 31/675 (2013.01); A61K 31/7088 (2013.01); A61K 31/713 (2013.01); A61K 33/24 (2013.01); A61K 38/395 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); A61K 47/48376 (2013.01); A61K 47/48384 (2013.01); A61K 47/48561 (2013.01); A61K 47/48715 (2013.01); A61K 48/00 (2013.01); C07K 16/2803 (2013.01); C07K 16/2833 (2013.01); C07K 16/2851 (2013.01); C07K 16/2887 (2013.01); C07K 16/30 (2013.01); C07K 16/3007 (2013.01); C07K 16/3092 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); A61N 2005/1098 (2013.01); C07K 2317/24 (2013.01); C07K 2317/77 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01);
Abstract

The present invention concerns improved methods and compositions for preparing SN-38 conjugates of proteins or peptides, preferably immunoconjugates of antibodies or antigen-binding antibody fragments. More preferably, the SN-38 is attached to the antibody or antibody fragment using a CL2A linker, with 1-12, more preferably 6 or less, most preferably 1-5 SN-38 moieties per antibody or antibody fragment. Most preferably, the immunoconjugate is prepared in large scale batches, with various modifications to the reaction scheme to optimize yield and recovery in large scale. Other embodiments concern optimized dosages and/or schedules of administration of immunoconjugate to maximize efficacy for disease treatment and minimize side effects of administration.


Find Patent Forward Citations

Loading…